Tapewire

Nasdaq · USD

MAZE

Maze Therapeutics, Inc.

Export transactions ↓
Tapewire entity
1775
SEC CIK
0001842295
Parsed reports
106

Last 12 months

Inside the activity.

0 purchase rows · 95 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202508
Jan 2026011
Feb 202609
Mar 202609
Apr 202606
May 202607
Jun 202608
Jul 202607
Aug 202606
Sep 2026021
Oct 202603

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 02, 2026 Filed Feb 4, 2026 21:25 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 5,936 $46.37 $275,271.32
Disclosure

SEC source: 0002050172-26-000009 · form4-02042026_090238.xml · nonDerivative · entry 4

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.20 to $47.17 per share, inclusive.

Read SEC document
February 02, 2026 Filed Feb 4, 2026 21:25 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 8,364 $45.89 $383,816.43
Disclosure

SEC source: 0002050172-26-000009 · form4-02042026_090238.xml · nonDerivative · entry 3

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,036

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.20 to $46.19 per share, inclusive.

Read SEC document
February 02, 2026 Filed Feb 4, 2026 21:25 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 600 $44.21 $26,523.00
Disclosure

SEC source: 0002050172-26-000009 · form4-02042026_090238.xml · nonDerivative · entry 2

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,400

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.15 to $44.29 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 and 4 of this Form 4.

Read SEC document
February 02, 2026 Filed Feb 4, 2026 21:25 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionCommon Stock 15,000 $10.42 $156,300.00
Disclosure

SEC source: 0002050172-26-000009 · form4-02042026_090238.xml · nonDerivative · entry 1

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
January 29, 2026 Filed Feb 2, 2026 21:21 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050167-26-000003 · form4-02022026_090232.xml · derivative · entry 5

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 66,643

Underlying: Common Stock · 7,500 shares

Expires 2031-04-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F5 · derivative.exercise_date: The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on March 17, 2025.

Read SEC document
January 29, 2026 Filed Feb 2, 2026 21:21 UTC SaleCommon Stock 2,800 $45.01 $126,022.40
Disclosure

SEC source: 0002050167-26-000003 · form4-02022026_090232.xml · nonDerivative · entry 4

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,503

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.54 to $45.53 per share, inclusive.

Read SEC document
January 29, 2026 Filed Feb 2, 2026 21:21 UTC SaleCommon Stock 3,500 $44.04 $154,146.65
Disclosure

SEC source: 0002050167-26-000003 · form4-02022026_090232.xml · nonDerivative · entry 3

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,303

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.51 to $44.49 per share, inclusive.

Read SEC document
January 29, 2026 Filed Feb 2, 2026 21:21 UTC SaleCommon Stock 1,200 $43.18 $51,821.28
Disclosure

SEC source: 0002050167-26-000003 · form4-02022026_090232.xml · nonDerivative · entry 2

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,803

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.49 to $43.46 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 and 4 of this Form 4.

Read SEC document
January 29, 2026 Filed Feb 2, 2026 21:21 UTC Exercise / conversionCommon Stock 7,500 $10.42 $78,150.00
Disclosure

SEC source: 0002050167-26-000003 · form4-02022026_090232.xml · nonDerivative · entry 1

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,003

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
January 22, 2026 Filed Jan 26, 2026 16:10 UTC
Bachrodt AmySVP, Finance
Exercise / conversionStock Option (Right to Buy) · Derivative 2,503 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050422-26-000005 · form4-01262026_090133.xml · derivative · entry 5

Bachrodt Amy · CIK 0002050422 · SVP, Finance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,869

Underlying: Common Stock · 2,503 shares

Expires 2032-02-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F4 · derivative.exercise_date: The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on March 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
January 22, 2026 Filed Jan 26, 2026 16:10 UTC
Bachrodt AmySVP, Finance
Exercise / conversionStock Option (Right to Buy) · Derivative 2,497 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050422-26-000005 · form4-01262026_090133.xml · derivative · entry 4

Bachrodt Amy · CIK 0002050422 · SVP, Finance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 486

Underlying: Common Stock · 2,497 shares

Expires 2031-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · derivative.exercise_date: The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on April 1, 2021, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
January 22, 2026 Filed Jan 26, 2026 16:10 UTC
Bachrodt AmySVP, Finance
SaleCommon Stock 5,000 $45.52 $227,612.00
Disclosure

SEC source: 0002050422-26-000005 · form4-01262026_090133.xml · nonDerivative · entry 3

Bachrodt Amy · CIK 0002050422 · SVP, Finance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,965

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.93 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
January 22, 2026 Filed Jan 26, 2026 16:10 UTC
Bachrodt AmySVP, Finance
Exercise / conversionCommon Stock 2,503 $10.42 $26,081.26
Disclosure

SEC source: 0002050422-26-000005 · form4-01262026_090133.xml · nonDerivative · entry 2

Bachrodt Amy · CIK 0002050422 · SVP, Finance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,965

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
January 22, 2026 Filed Jan 26, 2026 16:10 UTC
Bachrodt AmySVP, Finance
Exercise / conversionCommon Stock 2,497 $10.42 $26,018.74
Disclosure

SEC source: 0002050422-26-000005 · form4-01262026_090133.xml · nonDerivative · entry 1

Bachrodt Amy · CIK 0002050422 · SVP, Finance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,462

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 21:30 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 3,281 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0001555132-26-000006 · form4-01082026_090134.xml · derivative · entry 10

Sohn Catherine A. · CIK 0001555132 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,805

Underlying: Common Stock · 3,281 shares

Expires 2034-12-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vested or vests as to 1/36th of the total award monthly, with the first tranche vested on January 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 21:30 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 2,895 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0001555132-26-000006 · form4-01082026_090134.xml · derivative · entry 9

Sohn Catherine A. · CIK 0001555132 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 316

Underlying: Common Stock · 2,895 shares

Expires 2033-03-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested or vests as to 1/36th of the total award monthly, with the first tranche vested on April 1, 2023, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 21:30 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 20,744 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0001555132-26-000006 · form4-01082026_090134.xml · derivative · entry 8

Sohn Catherine A. · CIK 0001555132 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,744 shares

Expires 2031-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on February 2, 2024.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 21:30 UTC SaleCommon Stock 26,920 $39.11 $1,052,784.67
Disclosure

SEC source: 0001555132-26-000006 · form4-01082026_090134.xml · nonDerivative · entry 6

Sohn Catherine A. · CIK 0001555132 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.04 to $39.85 per share, inclusive.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 21:30 UTC Exercise / conversionCommon Stock 3,281 $10.42 $34,188.02
Disclosure

SEC source: 0001555132-26-000006 · form4-01082026_090134.xml · nonDerivative · entry 5

Sohn Catherine A. · CIK 0001555132 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,920

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 21:30 UTC Exercise / conversionCommon Stock 2,895 $10.42 $30,165.90
Disclosure

SEC source: 0001555132-26-000006 · form4-01082026_090134.xml · nonDerivative · entry 4

Sohn Catherine A. · CIK 0001555132 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,639

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 21:30 UTC Exercise / conversionCommon Stock 20,744 $10.42 $216,152.48
Disclosure

SEC source: 0001555132-26-000006 · form4-01082026_090134.xml · nonDerivative · entry 3

Sohn Catherine A. · CIK 0001555132 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,744

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 07, 2026 Filed Jan 9, 2026 21:51 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionStock Option (Right to Buy) · Derivative 25,156 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050172-26-000006 · form4-01092026_090123.xml · derivative · entry 3

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 312,407

Underlying: Common Stock · 25,156 shares

Expires 2032-10-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · derivative.exercise_date: The option vested as to 1/4th of the total award on October 3, 2023, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
January 07, 2026 Filed Jan 9, 2026 21:51 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 25,156 $40.20 $1,011,298.87
Disclosure

SEC source: 0002050172-26-000006 · form4-01092026_090123.xml · nonDerivative · entry 2

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.55 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 07, 2026 Filed Jan 9, 2026 21:51 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionCommon Stock 25,156 $10.42 $262,125.52
Disclosure

SEC source: 0002050172-26-000006 · form4-01092026_090123.xml · nonDerivative · entry 1

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,156

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:30 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 2,493 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0001555132-26-000006 · form4-01082026_090134.xml · derivative · entry 7

Sohn Catherine A. · CIK 0001555132 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,211

Underlying: Common Stock · 2,493 shares

Expires 2033-03-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested or vests as to 1/36th of the total award monthly, with the first tranche vested on April 1, 2023, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:30 UTC SaleCommon Stock 2,493 $38.62 $96,269.69
Disclosure

SEC source: 0001555132-26-000006 · form4-01082026_090134.xml · nonDerivative · entry 2

Sohn Catherine A. · CIK 0001555132 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.61 to $38.6225 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 2 of this Form 4.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:30 UTC Exercise / conversionCommon Stock 2,493 $10.42 $25,977.06
Disclosure

SEC source: 0001555132-26-000006 · form4-01082026_090134.xml · nonDerivative · entry 1

Sohn Catherine A. · CIK 0001555132 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,493

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 05, 2026 Filed Jan 6, 2026 21:31 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionStock Option (Right to Buy) · Derivative 412 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050172-26-000003 · form4-01062026_090146.xml · derivative · entry 6

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 337,563

Underlying: Common Stock · 412 shares

Expires 2032-10-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · derivative.exercise_date: The option vested as to 1/4th of the total award on October 3, 2023, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
January 05, 2026 Filed Jan 6, 2026 21:31 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 412 $40.00 $16,480.00
Disclosure

SEC source: 0002050172-26-000003 · form4-01062026_090146.xml · nonDerivative · entry 4

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
January 05, 2026 Filed Jan 6, 2026 21:31 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionCommon Stock 412 $10.42 $4,293.04
Disclosure

SEC source: 0002050172-26-000003 · form4-01062026_090146.xml · nonDerivative · entry 3

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 412

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 16:30 UTC
Bachrodt AmySVP, Finance
Exercise / conversionStock Option (Right to Buy) · Derivative 4,796 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050422-26-000003 · form4-01062026_090124.xml · derivative · entry 6

Bachrodt Amy · CIK 0002050422 · SVP, Finance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,983

Underlying: Common Stock · 4,796 shares

Expires 2031-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F5 · derivative.exercise_date: The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on March 1, 2025.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 16:30 UTC
Bachrodt AmySVP, Finance
Exercise / conversionStock Option (Right to Buy) · Derivative 204 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050422-26-000003 · form4-01062026_090124.xml · derivative · entry 5

Bachrodt Amy · CIK 0002050422 · SVP, Finance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,377

Underlying: Common Stock · 204 shares

Expires 2032-10-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F4 · derivative.exercise_date: The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on November 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 16:30 UTC
Bachrodt AmySVP, Finance
SaleCommon Stock 2,595 $39.57 $102,681.30
Disclosure

SEC source: 0002050422-26-000003 · form4-01062026_090124.xml · nonDerivative · entry 4

Bachrodt Amy · CIK 0002050422 · SVP, Finance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,965

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.15 to $39.99 per share, inclusive.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 16:30 UTC
Bachrodt AmySVP, Finance
SaleCommon Stock 2,405 $38.70 $93,072.30
Disclosure

SEC source: 0002050422-26-000003 · form4-01062026_090124.xml · nonDerivative · entry 3

Bachrodt Amy · CIK 0002050422 · SVP, Finance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,560

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.15 to $39.14 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 16:30 UTC
Bachrodt AmySVP, Finance
Exercise / conversionCommon Stock 4,796 $10.42 $49,974.32
Disclosure

SEC source: 0002050422-26-000003 · form4-01062026_090124.xml · nonDerivative · entry 2

Bachrodt Amy · CIK 0002050422 · SVP, Finance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,965

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 16:30 UTC
Bachrodt AmySVP, Finance
Exercise / conversionCommon Stock 204 $10.42 $2,125.68
Disclosure

SEC source: 0002050422-26-000003 · form4-01062026_090124.xml · nonDerivative · entry 1

Bachrodt Amy · CIK 0002050422 · SVP, Finance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,169

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 21:31 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionStock Option (Right to Buy) · Derivative 4,432 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050172-26-000003 · form4-01062026_090146.xml · derivative · entry 5

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 337,975

Underlying: Common Stock · 4,432 shares

Expires 2032-10-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · derivative.exercise_date: The option vested as to 1/4th of the total award on October 3, 2023, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 21:31 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 4,432 $40.43 $179,187.53
Disclosure

SEC source: 0002050172-26-000003 · form4-01062026_090146.xml · nonDerivative · entry 2

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.965 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 21:31 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionCommon Stock 4,432 $10.42 $46,181.44
Disclosure

SEC source: 0002050172-26-000003 · form4-01062026_090146.xml · nonDerivative · entry 1

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,432

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
December 30, 2025 Filed Dec 31, 2025 16:20 UTC
Bachrodt AmySVP, Finance
Exercise / conversionStock Option (Right to Buy) · Derivative 2,605 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050422-25-000007 · form4-12312025_091203.xml · derivative · entry 11

Bachrodt Amy · CIK 0002050422 · SVP, Finance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,581

Underlying: Common Stock · 2,605 shares

Expires 2032-10-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F7 · derivative.exercise_date: The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on November 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
December 30, 2025 Filed Dec 31, 2025 16:20 UTC
Bachrodt AmySVP, Finance
Exercise / conversionStock Option (Right to Buy) · Derivative 2,395 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050422-25-000007 · form4-12312025_091203.xml · derivative · entry 10

Bachrodt Amy · CIK 0002050422 · SVP, Finance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1

Underlying: Common Stock · 2,395 shares

Expires 2031-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F5 · derivative.exercise_date: The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on February 1, 2025.

Read SEC document
December 30, 2025 Filed Dec 31, 2025 16:20 UTC
Bachrodt AmySVP, Finance
SaleCommon Stock 5,000 $40.08 $200,407.00
Disclosure

SEC source: 0002050422-25-000007 · form4-12312025_091203.xml · nonDerivative · entry 7

Bachrodt Amy · CIK 0002050422 · SVP, Finance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,965

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.36 per share, inclusive.

Read SEC document
December 30, 2025 Filed Dec 31, 2025 16:20 UTC
Bachrodt AmySVP, Finance
Exercise / conversionCommon Stock 2,605 $10.42 $27,144.10
Disclosure

SEC source: 0002050422-25-000007 · form4-12312025_091203.xml · nonDerivative · entry 6

Bachrodt Amy · CIK 0002050422 · SVP, Finance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,965

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
December 30, 2025 Filed Dec 31, 2025 16:20 UTC
Bachrodt AmySVP, Finance
Exercise / conversionCommon Stock 2,395 $10.42 $24,955.90
Disclosure

SEC source: 0002050422-25-000007 · form4-12312025_091203.xml · nonDerivative · entry 5

Bachrodt Amy · CIK 0002050422 · SVP, Finance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,360

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
December 30, 2025 Filed Dec 31, 2025 21:24 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 100 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050167-25-000007 · form4-12312025_091220.xml · derivative · entry 7

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,143

Underlying: Common Stock · 100 shares

Expires 2031-04-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F5 · derivative.exercise_date: The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on March 17, 2025.

Read SEC document
December 30, 2025 Filed Dec 31, 2025 21:24 UTC SaleCommon Stock 100 $40.36 $4,036.00
Disclosure

SEC source: 0002050167-25-000007 · form4-12312025_091220.xml · nonDerivative · entry 5

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,503

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
December 30, 2025 Filed Dec 31, 2025 21:24 UTC Exercise / conversionCommon Stock 100 $10.42 $1,042.00
Disclosure

SEC source: 0002050167-25-000007 · form4-12312025_091220.xml · nonDerivative · entry 4

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,603

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
December 29, 2025 Filed Dec 31, 2025 21:22 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionStock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050172-25-000007 · form4-12312025_091232.xml · derivative · entry 4

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 342,407

Underlying: Common Stock · 45,000 shares

Expires 2032-10-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F4 · derivative.exercise_date: The option vested as to 1/4th of the total award on October 3, 2023, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
December 29, 2025 Filed Dec 31, 2025 21:22 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 17,200 $40.93 $703,930.64
Disclosure

SEC source: 0002050172-25-000007 · form4-12312025_091232.xml · nonDerivative · entry 3

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.73 to $41.51 per share, inclusive.

Read SEC document
December 29, 2025 Filed Dec 31, 2025 21:22 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 27,800 $40.34 $1,121,424.20
Disclosure

SEC source: 0002050172-25-000007 · form4-12312025_091232.xml · nonDerivative · entry 2

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,200

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.71 to $40.705 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.